(Q41056595)

26 September 2017

title

Schizophrenia and Alzheimer's disease: clinical and pathophysiologic analogies (English)

1 reference

26 September 2017

0 references

0 references

1 reference

White KE

1

1 reference

26 September 2017

Cummings JL

series ordinal

2

1 reference

26 September 2017

publication date

1 May 1996

1 reference

26 September 2017

published in

Comprehensive Psychiatry

1 reference

26 September 2017

volume

37

1 reference

26 September 2017

issue

3

1 reference

26 September 2017

page(s)

188-195

1 reference

Senile dementia of the Alzheimer type

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

The impact of dementia on the family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Negative v positive schizophrenia. Definition and validation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

The two-syndrome concept: origins and current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Molecular pathology of schizophrenia: more than one disease process?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Overview of depression and psychosis in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Alzheimer's disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

The nature of psychotic symptoms in senile dementia of the Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Cognitive deficits of patients with Alzheimer's disease with and without delusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Delusions in dementia syndromes: investigation of behavioral and neuropsychological correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Negative symptoms in schizophrenia. Definition and reliability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

The progression of personality changes in senile dementia of the Alzheimer's type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Computerized tomography of the brain in schizophrenic patients. A controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Ventricular enlargement in schizophrenia: definition and prevalence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Computed tomography of the brain in patients with acute psychosis and in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Computed tomography in schizophreniform disorder and other acute psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Cerebral ventricular enlargement in chronic schizophrenia. An association with poor response to treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Reduced temporal lobe areas in schizophrenia: preliminary evidences from a controlled multiplanar magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Regional brain glucose metabolism in chronic schizophrenia. A positron emission transaxial tomographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Regional cortical dysfunction in Alzheimer's disease as determined by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Cortical abnormalities in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Lesions of the nucleus ansae peduncularis in neuropsychiatric disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Cell loss in the hippocampus of schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Hippocampal pathologic findings in schizophrenia. A morphometric study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Organic delusions: phenomenology, anatomical correlations, and review

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

inferred from DOI database lookup

7 January 2021

based on heuristic

The current status of the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Selective loss of central cholinergic neurons in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Necropsy evidence of central cholinergic deficits in senile dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Pre- and postsynaptic neurochemical alterations in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Presynaptic cholinergic dysfunction in patients with dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

The dopamine hypothesis of schizophrenia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Physostigmine ameliorates the delusions of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Delusions in dementia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Depot neuroleptics in the treatment of behavioral disorders in patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

The inhibition of the conditioned response and the counteraction of schizophrenia by muscarinic stimulation of the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

The effects of physostigmine in phenothiazine resistant chronic schizophrenic patients: preliminary observations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Neuropathologic and neurochemical correlates of psychosis in primary dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

Neurofibrillary pathology in brains of elderly schizophrenics treated with neuroleptics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-440X%2896%2990035-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0010-440X(96)90035-8

1 reference

26 September 2017

1 reference